Ethanol Sclerotherapy for Primary and Recurrent Endometrioma Improves In Vitro Fertilization Pregnancy Outcomes: A Randomized Clinical Trial

Leila Shahsavari, Vajihe Hazari, Ashraf Aleyasin, Zeinab Samadi · 2026

Read Ethanol Sclerotherapy for Primary and Recurrent Endometrioma Improves In Vitro Fertilization Pregnancy Outcomes: A Randomized Clinical Trial by Leila Shahsavari, Vajihe Hazari, Ashraf Aleyasin, Zeinab Samadi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13458621.txt.

Description

Leila Shahsavari and colleagues randomize women with ovarian endometriomas to ethanol sclerotherapy or hormonal suppression before IVF. Endometriomas, cysts of stray uterine lining, blunt ovarian response, and removing them by surgery costs healthy tissue. Their 2026 single-blind trial enrolled 80 infertile women aged 20 to 40 with primary or recurrent cysts, 40 per arm. The treatment group had the cyst drained and ethanol instilled, while controls received Diphereline.

Baseline features and complication rates matched. Chemical pregnancy favored sclerotherapy at 40 against 20 percent, and clinical pregnancy at 32.5 against 15 percent, both significant. Embryo quality, conception, and implantation rates did not separate the groups. One in five treated cysts recurred within six months, the trade-off to weigh. The authors propose ethanol sclerotherapy as a tissue-sparing option over cystectomy for chosen IVF patients, noting the trial's modest size and single-cycle window when judging the gains.

Catalog record

CREATORLeila Shahsavari, Vajihe Hazari, Ashraf Aleyasin, Zeinab Samadi
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE23 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13458621

Browse the full library · About the Tower of Babel